WEHI Ventures and 66ten Fund
The 66ten fund, managed by WEHI Ventures, is a $66 million strategic investment initiative aimed at advancing groundbreaking medical discoveries from early-stage research to commercial viability. The fund focuses on pre-seed and seed investments, providing the necessary financial backing and commercial expertise to accelerate innovative healthcare solutions that could have a global impact.
The fund aims to bridge the gap between discovery and investable commercial ventures. Significant funding in the pre-seed and seed stages will advance innovations more quickly and help to gain global commercial competitiveness.
